Workshop report: Malaria vaccine development in Europe-preparing for the future. by Viebig, N, D'Alessio, F, Draper, S, Sim, B, Mordmüller, B, Bowyer, P, Luty, A, Jungbluth, S, Chitnis, C, Hill, A, Kremsner, P, Craig, A, Kocken, C, Leroy, O

Safety and Immunogenicity of the malaria vaccine candidate R21 adjuvanted with matrix-m1 in West African adult volunteers, Burkina Faso by Tiono, AB, Ouedraogo, A, Coulibaly, SA, Bougouma, EC, Ouedraogo, IN, Navin, V, Bowyer, G, Ewer, K, Viebig, N, Diarra, A, Glenn, G, Leroy, O, Hill, AV, Sirima, SB

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. by Kimani, D, Jagne, Y, Cox, M, Kimani, E, Bliss, C, Gitau, E, Ogwang, C, Afolabi, M, Bowyer, G, Collins, K, Edwards, N, Hodgson, S, Duncan, C, Spencer, A, Knight, MG, Drammeh, A, Anagnostou, N, Berrie, E, Moyle, S, Gilbert, S, Soipei, P, Okebe, J, Colloca, S, Cortese, R, Viebig, N

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal. by Mensah, V, Gueye, A, Ndiaye, M, Edwards, N, Wright, D, Anagnostou, N, Syll, M, Ndaw, A, Abiola, A, Bliss, C, Gomis, J, Petersen, I, Ogwang, C, Dieye, T, Viebig, N, Lawrie, A, Roberts, R, Nicosia, A, Faye, B, Gaye, O, Leroy, O, Imoukhuede, E, Ewer, K, Bejon, P, Hill, A, Cisse, B, MVVC Group

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Ken... by Ogwang, C, Afolabi, M, Kimani, D, Jagne, Y, Sheehy, S, Bliss, C, Duncan, C, Collins, K, Garcia Knight, M, Kimani, E, Anagnostou, N, Berrie, E, Moyle, S, Gilbert, S, Spencer, A, Soipei, P, Mueller, J, Okebe, J, Colloca, S, Cortese, R, Viebig, N, Roberts, R, Gantlett, K, Lawrie, A, Nicosia, A, Imoukhuede, E, Bejon, P, Urban, B, Flanagan, K, Ewer, K, Chilengi, R, Hill, A, Bojang, K